Abbott Laboratories stock gains 1.12 percent as settlement weighs

Published on 09/23/2026 at 12:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Abbott Laboratories stock closed at USD 104.13 on September 22, 2026, after a 1.12 percent gain. Trading volume was 2,637,689 shares, below average.

Modernes Diagnostik-Labor Abbott Laboratories US0028241000 — Abbott Laboratories US0028241000 zeigt modernes Diagnostik-Labor mit Wissenschaftlern in weißen Laborkitteln an Analysesystemen, Illustration mit AI erstellt.

Abbott Laboratories stock (ISIN US0028241000) closed at USD 104.13 on the NYSE on September 22, 2026, up 1.12 percent from the prior close. The move came as the company faced a USD 385 million settlement, giving the session a clear legal and market angle.

Settlement shapes the latest move

Abbott Laboratories traded at USD 104.01 during the September 22 session before finishing at USD 104.13. According to Ad Hoc News, the shares rose USD 1.03 while the settlement amount reached USD 385 million.

The market reaction was positive in absolute terms, but the trading activity was restrained. Volume totaled 2,637,689 shares, compared with reported average volume of 11,461,565 shares, so the 1.12 percent gain was achieved on activity equal to about 23.0 percent of that average.

Market value remains the key measure

A separate September 23, 2026 market snapshot put Abbott Laboratories at USD 103.69 on the NYSE, with market capitalization of USD 178.195 billion and volume of 8,383,900 shares. The same snapshot places the stock in a medical-device peer comparison, where the valuation remains materially larger than several listed healthcare companies.

That comparison matters because the settlement is a defined financial charge, while the share-price data show how the market was valuing the company around the event. The stock also recorded a 90-day share-price return of 14.59 percent, while its one-year total shareholder return was down 21.93 percent, according to Simply Wall St on September 23, 2026. The contrast between the 14.59 percent 90-day gain and the 21.93 percent one-year decline is the clearest quantified counterpoint to the latest daily rise.

Abbott Laboratories stock closes at USD 104.13

Abbott Laboratories stock closed at USD 104.13 on the NYSE on September 22, 2026, with a 1.12 percent daily gain and volume of 2,637,689 shares. The next valuation checkpoint is the balance between the USD 385 million settlement and the company market capitalization of USD 178.195 billion recorded in the September 23 market snapshot.